advertisement
11.4 Prostaglandins (15)
Showing records 1 to 15
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins13519 Vasoactive responses of U46619, PGF2α, latanoprost, and travoprost in isolated porcine ciliary arteries
Vysniauskiene I; Allemann R; Flammer J; Haefliger IO
Investigative Ophthalmology and Visual Science 2006; 47: 295-298
13457 A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components
Diestelhorst M; Larsson LI; European-Canadian Latanoprost Fixed Combination Study Group
Ophthalmology 2006; 113: 70-76
13546 Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma
Haneda M; Shirato S; Maruyama K; Ohno Y
Japanese Journal of Ophthalmology 2006; 50: 33-37
13478 Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication
Magacho L; Reis R; Shetty RK; Santos LC; Avila MP
Ophthalmology 2006; 113: 442-445
13365 A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma
Parmaksiz S; Yuksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
European Journal of Ophthalmology 2006; 16: 73-80
13446 Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension
Chiba T; Kashiwagi K; Chiba N; Tsukahara S
British Journal of Ophthalmology 2006; 90: 314-317
13266 A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy
Christensen TL; Poulsen PB; Holmstrom S; Walt JG; Vetrugno M
Current Medical Research and Opinion 2005; 21: 1837-1843
13415 Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma
Costagliola C; Parmeggiani F; Caccavale A; Sebastiani A
American Journal of Ophthalmology 2006; 141: 379-381
13305 Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medication
Hollo G; Vargha P; Kothy P
Current Medical Research and Opinion 2005; 21: 1943-1948
13304 Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma
Holmstrom S; Buchholz P; Walt J; Wickstrom J; Aagren M
Current Medical Research and Opinion 2005; 21: 1875-1883
13532 Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients
Kondo N; Sawada A; Yamamoto T; Taniguchi T
Japanese Journal of Ophthalmology 2006; 50: 20-24
13495 24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma
Konstas AG; Mikropoulos D; Kaltsos K; Jenkins JN; Stewart WC
Ophthalmology 2006; 113: 446-450
13364 Effects of latanoprost and GLC756, a novel dopamine D2 agonist and D1 antagonist, on cultured normal human dermal fibroblasts
Laengle UW; Markstein R; Pralet D; Greiner B; Roman D
European Journal of Ophthalmology 2006; 16: 67-72
13326 Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology 2006; 113: 239-246
13267 The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients - a European perspective
Tuil E; Hommer AB; Poulsen PB; Christensen TL; Buchholz P; Walt J; Holmstrom S
International Journal of Clinical Pract 2005; 59: 1011-1016
